Dec 19, 2017 12:50 pm UTC| Business
NEW YORK, Dec. 19, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allstate...
Premier Exhibitions Withdraws Sale Procedures, Cancelling Planned Auction of Company Assets
Dec 19, 2017 12:47 pm UTC| Business
ATLANTA, Dec. 19, 2017 -- Premier Exhibitions, Inc. (OTCQB:PRXIQ) the company that serves as salvor-in-possession and sole legal steward of the RMS Titanic wreck site, today announced that it has withdrawn the proposed...
Dec 19, 2017 12:40 pm UTC| Business
NEW YORK, Dec. 19, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fluor Corporation...
Dec 19, 2017 12:35 pm UTC| Business
NEW YORK, Dec. 19, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Weight Watchers...
Dec 19, 2017 12:31 pm UTC| Business
SHIRE RECEIVES FDA CLEARANCE FOR MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] TO HELP PERSONALIZE CARE FOR HEMOPHILIA A First and only FDA-cleared PK dosing software to support healthcare...
Dec 19, 2017 12:31 pm UTC| Business
HanX to commercialize in Greater China: Onconova retains rights in rest of the worldHanX will fund studies towards Investigational New Drug (IND) applications in both the US and ChinaAgreement includes licensing fee,...
BioCorRx Submits Pre-IND Package to FDA for its Naltrexone Implant, BICX102
Dec 19, 2017 12:30 pm UTC| Business
ANAHEIM, CA, Dec. 19, 2017 -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that it has submitted its...